Piper Sandler Reiterates Its ‘Overweight' Rating on AbbVie Inc. (ABBV) with a $231 PT [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
Piper Sandler Reiterates Its ‘Overweight' Rating on AbbVie Inc. (ABBV) with a $231 PT On September 12, 2025, Piper Sandler reiterated its ‘Overweight' rating on AbbVie Inc. (NYSE:ABBV) with a $231 price target. This comes after the company settled with abbreviated New Drug Application (ANDA) filers over Rinvoq. The agreement delays generic entry until April 2037, which is four years beyond the expiration of key composition IP in 2033. Thus, it provides AbbVie Inc. (NYSE:ABBV) with an extended exclusivity window. The investment firm noted that the final years of exclusivity often result in peak sales with lower R&D and marketing costs. Looking ahead, analysts believe the settlement enhances the company's long-term earnings outlook and justifies multiple expansion from its current value, as Rinvoq is projected to surpass $10 billion in annual U.S. sales by 2030. AbbVie Inc. (NYSE:ABBV), a global biopharmaceutical company, develops and markets innovative medicines across immunolog
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- Top Stock Reports for AbbVie, Coca-Cola & Chevron [Yahoo! Finance]Yahoo! Finance
- 2 Dividend Kings Quietly Beating the Market This Year [Yahoo! Finance]Yahoo! Finance
- What AbbVie (ABBV)'s Restructured OSE Immunology Partnership Means For Shareholders [Yahoo! Finance]Yahoo! Finance
- ????????????????????????????2035????128???????????? [CNET News]CNET News
- Vanguard Health Care Fund's Strategic Moves: Spotlight on AbbVie Inc [Yahoo! Finance]Yahoo! Finance
ABBV
Earnings
- 10/31/25 - Beat
ABBV
Sec Filings
- 11/20/25 - Form F-6
- 11/4/25 - Form 10-Q
- 10/31/25 - Form 8-K
- ABBV's page on the SEC website